ask="54.97"
ask_size="1000"
average_daily_volume="1127330"
bid="41.20"
bid_size="100"
book_value="4.05"
change="+0.36"
change_from_200_day_moving_average="-2.91"
change_from_50_day_moving_average="2.71"
change_from_52_week_high="-11.55"
change_From_52_week_low="12.35"
change_in_percent="+0.83%"
close="43.60"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.45"
ebitda="-134.59M"
eps_estimate_current_year="-1.63"
eps_estimate_next_quarter="-0.48"
eps_estimate_next_year="-1.92"
ex_dividend_date="N/A"
float_shares="85781000"
high="44.66"
high_52_weeks="55.15"
last_trade_date="2/7/2017"
last_trade_price="43.60"
last_trade_size="28434"
last_trade_time="4:00pm"
low="42.93"
low_52_weeks="31.25"
market_capitalization="3.79B"
moving_average_200_day="46.51"
moving_average_50_day="40.89"
name="Neurocrine Biosciences
Inc."
notes="N/A"
one_year_target_price="66.92"
open="43.41"
pe_ratio="N/A"
peg_ratio="0.73"
percent_change_from_200_day_moving_average="-6.25%"
percent_change_from_50_day_moving_average="+6.63%"
percent_change_from_52_week_high="-20.94%"
percent_change_from_52_week_low="+39.52%"
previous_close="43.24"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="10.68"
price_per_sales="250.42"
revenue="15.00M"
shares_outstanding="86871000"
short_ratio="3.10"
stock_exchange="NMS"
symbol="NBIX"
volume="862418"
weeks_range_52="31.25 - 55.15"
